Default company panoramic image
9771cda2 0ac2 45ec b23b 6c900010783d

NexGen Medical Systems, Inc.

NexGen seeks $750,000 to increase sales of a breakthrough FDA-approved medical device that removes blood clots in DVT and stroke patients

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Melbourne, FL, USA
  • Currency USD
  • Founded February 2004
  • Employees 7
  • Website nexgenmedsystem.com

Company Summary

NexGen's experienced management team is focused on commercializing a total procedural solution for the removal of blood clots. NexGen is raising $750,000 to increase sales of its XCOIL product line to interventional physicians who treat patients with DVT or stroke. In 24 months, we expect to be at a major inflection point in valuation in line to pursue a liquidity event through acquisition by a large med-tech company at an attractive valuation.

Team

  • Default avatar
    John Kucharczyk
    President / CEO
    Unconfirmed

    Serial entrepreneur since 1996; co-founder & CEO NexGen since 2004; co-founder and executive with Image-Guided Neurologics and 2 other med-techs with successful exits; previously professor radiology & neurosurgery University of California San Francisco & University of Minnesota; author of 40 patents; co-inventor of several medical devices under development at NexGen

  • Default avatar
    Joe Rafferty
    VP Business Development
    Unconfirmed

    VP Business Development at NexGen since 2010; previously CEO National Medical Sales, Executive at Pathway Medical, Synthes Spine, Guidant, C.R. Bard

  • Default avatar
    Matt Solar
    VP Product Development
    Unconfirmed

    VP Product Development at NexGen since 2008; 20 years experience in design, development and manufacturing medical devices including with Medtronic; previously VP Image-Guided Neurologics ; Manager at 4 other med-tech startups; holds more than 40 patents

  • Default avatar
    Dino De Cicco
    Director of Engineering
    Unconfirmed

    Appointed as Director of Engineering in September 2008. Previously, served as R&D Manager at Bacchus Vascular from 2000-2005 (acquired by Covidien), as Product Development Engineer at Appriva Medical from 1999-2000 (acquired by ev3, Inc.), and as Product Development Engineer at Medtronic AneuRx from 1996-1999. Holds a B.Sc. in Biomedical Engineering from University of Southern California, and has fourteen patents related to medical devices.

Advisors

  • Default avatar
    Dorsey & Whitney, Seattle
    Lawyer
    Unconfirmed
    Default avatar
    Stutzman & C0., Minneapolis
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    LifeTech Developments Fund I
    Unconfirmed
    Default avatar
    Sacramento Angels
    Unconfirmed
    Default avatar
    Private individual investors
    Unconfirmed